Log in
Enquire now
‌

US Patent 7390799 Apoptosis promoters

Patent 7390799 was granted and assigned to Abbott on June, 2008 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
Abbott
Abbott
Date Filed
May 12, 2006
Date of Patent
June 24, 2008
Patent Application Number
11432937
Patent Citations Received
‌
US Patent 12118414 BCL-2 proteins degraders for cancer treatment
0
‌
US Patent 11926625 HPK1 antagonists and uses thereof
0
‌
US Patent 11932635 CRBN ligands and uses thereof
0
‌
US Patent 11932624 MDM2 degraders and uses thereof
0
‌
US Patent 11938137 Lipid prodrugs of mycophenolic acid and uses thereof
0
‌
US Patent 11975073 Lipid prodrugs of neurosteroids
0
‌
US Patent 12006329 Protein degraders and uses thereof
0
‌
US Patent 12071442 Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonists
0
‌
US Patent 12077555 STAT degraders and uses thereof
0
‌
US Patent 12084438 GCN2 inhibitors and uses thereof
0
•••
Patent Inventor Names
Christopher L. Lynch
0
Milan Bruncko
0
Steven W. Elmore
0
William J. McClellan
0
Xiahong Song
0
Xilu Wang
0
Hong Ding
0
Aaron R. Kunzer
0
Cheol Min Park
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7390799
Patent Primary Examiner
‌
Kahsay T. Habte

Find more entities like US Patent 7390799 Apoptosis promoters

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.